SMDG: UK Life Sciences Innovator 2023
SMDG has been recognised as a UK Life Sciences Innovator 2023. The announcement which was recently made, followed a rigorous application and screening process of hundreds of companies by the UK Department for Business and Trade. Learn more about the UK Life Sciences Innovators Showcase,
Rosalind Franklin Society Briefings features Dr. Farhangrazi
The Rosalind Franklin Society Briefings, a newsletter has highlighted the article “My path to heading a biotech company.” The Rosalind Franklin Society is an interdisciplinary, and international society which recognizes, fosters, and advances the important contributions of women in the life sciences and affiliated disciplines, and celebrates the contributions of these outstanding women.
Dr. Farhangrazi joins WIN
Dr Farhangrazi has joined the cohort of Women's International Networking Programme 2023/2024. The programme has been designed to increase the participation of women-led businesses in international trade with virtual training, business mentoring, panel discussions and peer to peer networking opportunities.
Dr Farhangrazi joins the editorial board
Dr Farhangrazi has joined the Editorial Board of Technological and Methodological Advances in Drug Delivery (specialty section of Frontiers in Drug Delivery).
Professor Moghimi gives two talks at CLINAM
Professor Moghimi, Co-Founder of SMDG and Professor of Pharmaceutics and Nanomedicine at Newcastle University gives two talks at the CLINAM summit in Basel, Switzerland, October 2023.
Innovation Showcase Company 2023
SMDG was recognized among the innovative companies during the VentureFest in May 2023 by the Innovation SuperNetwork NE. UK.